Cardiac resynchronisation as a rescue therapy in patients with catecholamine-dependent overt heart failure: Results from a short and mid-term study

European Journal of Heart Failure

Volumn 10, Issue 3, 2008, Pages 291-297

  Milliez, Paul ^a   Thomas, Olivier ^b   Haggui, Abdeddayem ^a   Schurando, Patrick ^a   Squara, Pierre ^b   Cohen Solal, Alain ^a   Mebazaa, Alexandre ^a   Leenhardt, Antoine ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Ambroise Pare Clinic   (France)

Author keywords

Acute decompensated heart failure; CRT; Rescue

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; LEVOSIMENDAN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPOTENSION; HYPOXEMIA; IMPLANTATION; MALE; PRIORITY JOURNAL; QRS COMPLEX; SUDDEN DEATH; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; URINE VOLUME; VALIDATION PROCESS; WEANING;

AGED; CARDIAC OUTPUT, LOW; CARDIAC PACING, ARTIFICIAL; CATECHOLAMINES; FEMALE; HEART CONDUCTION SYSTEM; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 40249093759     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.02.006     Document Type: Article

References (25)

1. Auricchio A., Stellbrink C., Sack S., et al., Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39 (2002) 2026-2033
2. Cazeau S., Leclercq C., Lavergne T., et al., Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 (2001) 873-880
3. St John Sutton M.G., Plappert T., Abraham W.T., et al., Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
4. Young J.B., Abraham W.T., Smith A.L., et al., Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289 (2003) 2685-2694
5. Bristow M.R., Saxon L.A., Boehmer J., et al., Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
6. Auricchio A., Stellbrink C., Butter C., et al., Pacing Therapies in Congestive Heart Failure II Study Group. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 42 (2003) 2109-2116
7. Lozano I., Bocchiardo M., Achtelik M., et al., VENTAK CHF/CONTAK CD Investigators Study Group. Impact of biventricular pacing on mortality in a randomized crossover study of patients with heart failure and ventricular arrhythmias. Pacing Clin Electrophysiol 23 (2000) 1711-1712
8. Cleland J.G., Daubert J.C., Erdmann E., et al., Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
9. Brecker S.J., Xiao H.B., Sparrow J., and Gibson D.G. Effects of dual chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 340 (1992) 1308-1312
10. Nishimura R.A., Hayes D.L., Holmes Jr. D.R., and Tajik AJ. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute doppler and catheterization hemodynamic study. J Am Coll Cardiol 25 (1995) 281-288
11. Leclercq C., Cazeau S., Le Breton H., et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 32 (1998) 1825-1831
12. Auricchio A., Stellbrink C., Block M., et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 99 (1999) 2993-3001
13. Nelson G.S., Berger R.D., Fetics B.J., et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 102 (2000) 3053-3059
14. Breithardt O.A., Sinha A.M., Schwammenthal E., et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 41 (2003) 765-770
15. ACC/AHA. 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol 46 (2005) 1116-1143
16. The Task Force on Acute Heart Failure of the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 26 (2005) 384-416
17. Slawsky M.T., Colucci W.S., Gottlieb S.S., et al., Study Investigators. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 102 (2000) 2222-2227
18. Hollenberg S.M., Kavinski C.J., and Parrillo J.E. Cardiogenic shock. Ann Intern Med 131 (1999) 47-59
19. Hochman J.S., Sleeper L.A., White H.D., et al., SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. One-year survival following early revascularization for cardiogenic shocks. JAMA 285 (2001) 190-192
20. Bristow M.R., Hershberger R.E., Port J.D., et al. ß-Adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation 82 (1990) I12-I25
21. Unverferth D.A., Blanford M., Kates R.E., and Leier C.V. Tolerance to dobutamine after a 72 hour continuous infusion. Am J Med 69 (1980) 262-266
22. Colucci W.S., Leatherman G.F., Ludmer P.L., and Gauthier D.F. ß-Adrenergic inotropic responsiveness of patients with heart failure: studies with intracoronary dobutamine infusion. Circ Res 61 (1987) I82-I86
23. Cowburn H., Patel P.J., Jolliffe R.E., Wald R.W., and Parker J.D. Cardiac resynchronisation therapy: an option for inotrope-supported patients with end-stage heart failure?. Eur J Heart Fail 7 (2005) 215-217
24. Konstantino Y., Iakobishvili Z., Arad O., et al. Urgent cardiac resynchronization therapy in patients with decompensated chronic heart failure receiving inotropic therapy. A case series. Cardiology 106 (2006) 59-62
25. James K.B., Militello M., Barbara G., and Wilkoff B.L. Biventricular pacing for heart failure patients on inotropic support: a review of 38 consecutive cases. Tex Heart Inst J 33 (2006) 19-22